Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raed Alroughani

Showing results (81-90 of 223) with videos related to

Pageof 23
Sort By:
Neurological Research|June 23, 2024
Real-world experiences of migraine patients on Erenumab: a Kuwait single center cohortJasem Youssef Al-Hashel, Raed Alroughani, Fatemah Alshaf, et al.
Neurology and Therapy|June 22, 2020
Disease-Modifying Drugs and Family Planning in People with Multiple Sclerosis: A Consensus Narrative Review from the Gulf RegionRaed Alroughani, Jihad Inshasi, Abdullah Al-Asmi, et al.
Neurology and Therapy|June 17, 2021
Expert Consensus and Narrative Review on the Management of Multiple Sclerosis in the Arabian Gulf in the COVID-19 Era: Focus on Disease-Modifying Therapies and Vaccination Against COVID-19Jihad Inshasi, Raed Alroughani, Abdullah Al-Asmi, et al.
Frontiers in Neurology|February 15, 2021
Onabotulinumtoxin A Improves Psychological Aspects in Chronic Migraine PatientsJasem Youssef Al-Hashel, Hasan Kh Ashkanani, Ohood Almutairi, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|June 21, 2016
Risk Factors, Subtypes, and Outcome of Ischemic Stroke in Kuwait: A National StudyJasem Y Al-Hashel, Al-Alya Al-Sabah, Samar F Ahmed, et al.
Neurology and Therapy|June 22, 2021
Expert Consensus and Narrative Review on the Management of Multiple Sclerosis in the Arabian Gulf in the COVID-19 Era: Focus on Disease-Modifying Therapies and Vaccination Against COVID-19Jihad Inshasi, Raed Alroughani, Abdullah Al-Asmi, et al.
Postgraduate Medicine|February 25, 2020
Expert consensus from the Arabian Gulf on selecting disease-modifying treatment for people with multiple sclerosis according to disease activityRaed Alroughani, Jihad Inshasi, Abdullah Al-Asmi, et al.
Neurology and Therapy|November 5, 2025
Guiding Multiple Sclerosis Care: An Update to the 2013 Consensus Statement from the MS in the 21st Century Steering GroupRaed Alroughani, Elisabeth G Celius, Helen Gray, et al.
Neurology and Therapy|March 19, 2026
International Expert Opinion on Optimal Switching to Cladribine Tablets from Other High-Efficacy Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: Opportunities and ChallengesAndrew Chan, Raed Alroughani, Massimiliano Calabrese, et al.
Multiple Sclerosis and Related Disorders|June 17, 2019
Risk of relapses during pregnancy among multiple sclerosis patientsRaed Alroughani, Saeed Akhtar, Maya Zeineddine, et al.
Pageof 23

Showing results (81-90 of 223) with videos related to

Sort By:
Pageof 23
Neurological Research|June 23, 2024
Real-world experiences of migraine patients on Erenumab: a Kuwait single center cohortJasem Youssef Al-Hashel, Raed Alroughani, Fatemah Alshaf, et al.
Neurology and Therapy|June 22, 2020
Disease-Modifying Drugs and Family Planning in People with Multiple Sclerosis: A Consensus Narrative Review from the Gulf RegionRaed Alroughani, Jihad Inshasi, Abdullah Al-Asmi, et al.
Neurology and Therapy|June 17, 2021
Expert Consensus and Narrative Review on the Management of Multiple Sclerosis in the Arabian Gulf in the COVID-19 Era: Focus on Disease-Modifying Therapies and Vaccination Against COVID-19Jihad Inshasi, Raed Alroughani, Abdullah Al-Asmi, et al.
Frontiers in Neurology|February 15, 2021
Onabotulinumtoxin A Improves Psychological Aspects in Chronic Migraine PatientsJasem Youssef Al-Hashel, Hasan Kh Ashkanani, Ohood Almutairi, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|June 21, 2016
Risk Factors, Subtypes, and Outcome of Ischemic Stroke in Kuwait: A National StudyJasem Y Al-Hashel, Al-Alya Al-Sabah, Samar F Ahmed, et al.
Neurology and Therapy|June 22, 2021
Expert Consensus and Narrative Review on the Management of Multiple Sclerosis in the Arabian Gulf in the COVID-19 Era: Focus on Disease-Modifying Therapies and Vaccination Against COVID-19Jihad Inshasi, Raed Alroughani, Abdullah Al-Asmi, et al.
Postgraduate Medicine|February 25, 2020
Expert consensus from the Arabian Gulf on selecting disease-modifying treatment for people with multiple sclerosis according to disease activityRaed Alroughani, Jihad Inshasi, Abdullah Al-Asmi, et al.
Neurology and Therapy|November 5, 2025
Guiding Multiple Sclerosis Care: An Update to the 2013 Consensus Statement from the MS in the 21st Century Steering GroupRaed Alroughani, Elisabeth G Celius, Helen Gray, et al.
Neurology and Therapy|March 19, 2026
International Expert Opinion on Optimal Switching to Cladribine Tablets from Other High-Efficacy Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: Opportunities and ChallengesAndrew Chan, Raed Alroughani, Massimiliano Calabrese, et al.
Multiple Sclerosis and Related Disorders|June 17, 2019
Risk of relapses during pregnancy among multiple sclerosis patientsRaed Alroughani, Saeed Akhtar, Maya Zeineddine, et al.
Pageof 23